Focal adhesion kinase (FAK) is a non-receptor tyro-

Biomineralization of the ferritin iron core involves a complex series of events in which H2O2 is produced during iron oxidation by O2 at a dinuclear centre, the ‘ferroxidase site’, located on the H-subunit of mammalian proteins. Rapid-freeze quench Mössbauer spectroscopy was used to probe the early events of iron oxidation and mineralization in recombinant human ferritin containing 24 H-subunits. The spectra reveal that a μ-1,2-peroxodiFe(III) intermediate (species P) with Mössbauer parameters δ (isomer shift) = 0.58mm/s and ΔEQ (quadrupole splitting) = 1.07mm/s at 4.2K is formed within 50ms of mixing Fe(II) with the apoprotein. This intermediate accounts for almost all of the iron in the sample at 160ms. It subsequently decays within 10s to form a μ-oxodiFe(III)—protein complex (species D), which partially vacates the ferroxidase sites of the protein to generate Fe(III) clusters (species C) at a reaction time of 10min. The intermediate peroxodiFe(III) complex does not decay under O2-limiting conditions, an observation suggesting inhibition of decay by unreacted Fe(II), or a possible role for O2 in ferritin biomineralization in addition to that of direct oxidation of iron(II).

Background: FAK localization to focal adhesions is essential for its activation and function. Localization of FAK is mediated through the C-terminal focal adhesion targeting (FAT) domain. Recent structural analyses have revealed two paxillin-binding sites in the FAT domain of FAK. To define the role of paxillin binding to each site on FAK, point mutations have been engineered to specifically disrupt paxillin binding to each docking site on the FAT domain of FAK individually or in combination.

No abstract

No abstract